EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Generation and Characterization of Novel Pan‐Cancer Anti‐uPAR Fluorescent Nanobodies as Tools for Image‐Guided Surgery

Łukasz Mateusiak iD, Sam Floru, Timo W M De Groof, Janne Wouters, Noemi B Declerck, Pieterjan Debie, Simone Janssen, Katty Zeven, Janik Puttemans, Cécile Vincke, Karine Breckpot, Nick Devoogdt und 1 weitere

Advanced Science · 2024

DOI: 10.1002/advs.202400700 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Łukasz Mateusiak und 12 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Molecular Imaging and Therapy, Vrije Universiteit Brussel (VUB), MITH, Laarbeeklaan 103, Brussels, 1090, Belgium. Hauptthemen laut MEDLINE: Single-Domain Antibodies, Receptors, Urokinase Plasminogen Activator, Surgery, Computer-Assisted. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stichting Tegen Kanker, Strategic Research Program, Industrial Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fluorescence molecular imaging plays a vital role in image‐guided surgery. In this context, the urokinase plasminogen activator receptor (uPAR) is an interesting biomarker enabling the detection and delineation of various tumor types due to its elevated expression on both tumor cells and the tumor microenvironment. In this study, anti‐uPAR Nanobodies (Nbs) are generated through llama immunization with human and murine uPAR protein. Extensive in vitro characterization and in vivo testing with radiolabeled variants are conducted to assess their pharmacokinetics and select lead compounds. Subsequently, the selected Nbs are converted into fluorescent agents, and their application for fluorescence‐guided surgery is evaluated in various subcutaneous and orthotopic tumor models. The study yields a panel of high‐affinity anti‐uPAR Nbs, showing specific binding across multiple types of cancer cells in vitro and in vivo. Lead fluorescently‐labeled compounds exhibit high tumor uptake with high contrast at 1 h after intravenous injection across all assessed uPAR‐expressing tumor models, outperforming a non‐targeting control Nb. Additionally, rapid and accurate tumor localization and demarcation are demonstrated in an orthotopic human glioma model. Utilizing these Nbs can potentially enhance the precision of surgical tumor resection and, consequently, improve survival rates in the clinic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Single-Domain AntibodiesReceptors, Urokinase Plasminogen ActivatorSurgery, Computer-AssistedAnimalsMiceHumansDisease Models, AnimalCell Line, TumorOptical ImagingNeoplasmsFluorescent DyesCamelids, New World

Stichwörter der Autor:innen

fluorescence molecular imagingfluorescence‐guided surgerysingle‐domain antibodiesurokinase plasminogen activator receptor

Substanzen

Single-Domain AntibodiesReceptors, Urokinase Plasminogen ActivatorFluorescent Dyes

Autor:innen und Institutionen

  • Laboratory for Molecular Imaging and Therapy, Vrije Universiteit Brussel (VUB), MITH, Laarbeeklaan 103, Brussels, 1090, Belgium.
  • Faculty of Veterinary Medicine, Small Animal Department, Ghent University (UGent), Salisburylaan 133, Merelbeke, 9820, Belgium.
  • Laboratory for Cellular and Molecular Immunology, Vrije Universiteit Brussel (VUB), Pleinlaan 2, Brussels, 1050, Belgium.
  • Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Pleinlaan 2, Brussels, 1050, Belgium.
  • Laboratory for Molecular and Cellular Therapy, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, Brussels, 1090, Belgium.

ORCID-Profile: Łukasz Mateusiak

Förderung

  • Stichting Tegen Kanker
  • Strategic Research Program
  • Industrial Research Fund
  • Fonds Wetenschappelijk Onderzoek

Zitieren

APA

Mateusiak, Ł., Floru, S., De Groof, T. W. M., Wouters, J., Declerck, N. B., Debie, P., Janssen, S., Zeven, K., Puttemans, J., Vincke, C., Breckpot, K., Devoogdt, N., & Hernot, S. (2024). Generation and Characterization of Novel Pan‐Cancer Anti‐uPAR Fluorescent Nanobodies as Tools for Image‐Guided Surgery. Advanced Science. https://doi.org/10.1002/advs.202400700

Vancouver

Mateusiak Ł, Floru S, De Groof TWM, Wouters J, Declerck NB, Debie P, et al. Generation and Characterization of Novel Pan‐Cancer Anti‐uPAR Fluorescent Nanobodies as Tools for Image‐Guided Surgery. Advanced Science. 2024. doi:10.1002/advs.202400700

BibTeX
@article{Mateusiak2024,
  author = {Mateusiak, Łukasz and Floru, Sam and De Groof, Timo W M and Wouters, Janne and Declerck, Noemi B and Debie, Pieterjan and Janssen, Simone and Zeven, Katty and Puttemans, Janik and Vincke, Cécile and Breckpot, Karine and Devoogdt, Nick and Hernot, Sophie},
  title = {Generation and Characterization of Novel Pan‐Cancer Anti‐uPAR Fluorescent Nanobodies as Tools for Image‐Guided Surgery},
  journal = {Advanced Science},
  year = {2024},
  doi = {10.1002/advs.202400700}
}
Kostenlos starten →